Invictus Private Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$291K Buy
243
+9
+4% +$9.2K 0.02% 76
2026
Q1
$215K Buy
234
+9
+4% +$9.12K 0.01% 80
2025
Q4
$242K Buy
+225
New +$215K 0.01% 73
2025
Q2
Sell
-265
Closed -$219K 88
2025
Q1
$219K Sell
265
-91
-26% -$75.7K 0.02% 76
2024
Q4
$275K Sell
356
-65
-15% -$53.8K 0.02% 74
2024
Q3
$373K Buy
421
+16
+4% +$14.4K 0.03% 64
2024
Q2
$367K Sell
405
-5
-1% -$4K 0.03% 64
2024
Q1
$319K Sell
410
-16
-4% -$11.4K 0.03% 74
2023
Q4
$248K Hold
426
0.02% 85
2023
Q3
$229K Sell
426
-18
-4% -$9.28K 0.03% 87
2023
Q2
$208K Buy
+444
New +$186K 0.02% 89

Other funds holding LLY

Invictus Private Wealth's LLY Position: Q2 2026 in Review

Invictus Private Wealth increased its Eli Lilly (LLY) stake by 3.8% in Q2 2026, buying an estimated $9.2K and bringing the position to 243 shares worth $291K. The position accounts for 0.02% of the portfolio, ranked #76.

Invictus Private Wealth first reported a position in LLY in Q2 2023 and has held it in 11 quarters since. The position peaked at $373K in Q3 2024. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Invictus Private Wealth held 243 shares of Eli Lilly worth $291K as of Q2 2026.
  • Invictus Private Wealth bought 9 Eli Lilly shares in Q2 2026, an estimated $9.2K.
  • Eli Lilly made up 0.02% of Invictus Private Wealth's portfolio in Q2 2026, its #76 holding.
  • Invictus Private Wealth first reported a position in Eli Lilly in Q2 2023 and has held it in 11 quarters since.
  • Invictus Private Wealth's Eli Lilly position peaked at $373K in Q3 2024.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Invictus Private Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.